2-{3-[(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)amino]propyl}-3(2H) -pyridazinone hydrochloride (1:1)

Names

[ CAS No. ]:
110714-10-8

[ Name ]:
2-{3-[(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)amino]propyl}-3(2H) -pyridazinone hydrochloride (1:1)

[Synonym ]:
Guvacolinhydrobromid
methyl 1,2,5,6-tetrahydronicotinate hydrobromide
GYKI-12 743
1,2,5,6-Tetrahydronicotinic Acid Methyl Ester Hydrobromide
norarecoline
1,2,5,6-Tetrahydro-nicotinic Acid Hydrochloride
1,2,5,6-Tetrahydro-pyridin-3-carbonsaeure-methylester,Hydrobromid
1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester hydrobromide
Guvacoline Hydrobromide
Guvacine Methyl Ester Hydrobromide

Chemical & Physical Properties

[ Boiling Point ]:
464.9ºC at 760mmHg

[ Molecular Formula ]:
C16H20ClN3O3

[ Molecular Weight ]:
337.80100

[ Flash Point ]:
235ºC

[ Exact Mass ]:
337.11900

[ PSA ]:
65.38000

[ LogP ]:
2.25590

[ Vapour Pressure ]:
8.02E-09mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UR6340000
CHEMICAL NAME :
3(2H)-Pyridazinone, 2-(3-(((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)amino )propyl)-, monohydrochloride
CAS REGISTRY NUMBER :
110714-10-8
LAST UPDATED :
199806
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C16-H19-N3-O3.Cl-H
MOLECULAR WEIGHT :
337.84

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4826845
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
98 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 14,622,1989
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4826845
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
160 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4826845

Related Compounds

  • 4-(tert-Butyl) 2-ethyl 6-chloro-2,3-dihydro-4H-benzo[b][1,4]oxazine-2,4-dicarboxylate
  • N-(2-hydroxy-6-methoxyphenyl)propionamide
  • tert-Butyl 5-formyl-3,4-dihydroquinoline-1(2H)-carboxylate
  • [1-(2-phenoxyethyl)-3,4-dihydro-2H-quinolin-5-yl]methanol
  • tert-butyl 5-(hydroxymethyl)-3,4-dihydroquinoline-1(2H)-carboxylate
  • Methyl 2-oxo-1-phenyl-1,2,3,4-tetrahydroquinoline-7-carboxylate
  • Tert-butyl 4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidine-1-carboxylate
  • 8-Chloro-1-iodo-3-methylimidazo[1,5-a]pyrazine
  • 1-Methyl-4-[(1-methyl-3-pyrrolidinyl)methyl]piperazine
  • N-Benzyl-4-(morpholinomethyl)-2-(3-phenylpropanamido)thiazole-5-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.